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Abstract 
Background: To assess the attitudes and practices 
of parents of Beta-Thalassaemia Major children 
regarding Chorionic Villous Sampling (CVS), as 
prenatal diagnosis in subsequent pregnancies. 
Methods: In this cross-sectional study a pre-
designed questionnaire was used to evaluate the 
socio-demographic profile and attitudes of parents of 
210 registered thalassaemic children, regarding 
CVS.Only those parents who had one or more 
pregnancies after the index case were included in the 
study. Results were entered and analyzed on SPSS 
version 20. 
Results: After the index case, 36.2% parents 
underwent CVS in all subsequent pregnancies . The 
common reasons not to utilize this facility were lack 
of knowledge (47.7%), careless attitude (41.7%), 
family pressure (4.4%) and financial issues (1.5%). 
Religious reason was not found in any of the cases. 
Majority of the families (54.3%) belonged to lower 
middle class financial status. There was a significant 
association between CVS practice and educational 
level of the mother and genetic counselling at the 
time of diagnosis of index case.  In future 
pregnancies, 52.8% parents had no planning, while 
15.7% showed interest in undergoing CVS in next 
pregnancies. 
Conclusion: Despite the availability of CVS in the 
country, very few families had opted for it; the major 
reasons being lack of knowledge, careless attitude 
and family pressure. As against the common 
thought, religious reason was not a significant factor. 
Key Words: Prenatal diagnosis, Chorionic Villous 
Sampling, Beta-Thalassaemia Major. 
 
Introduction 
Beta-Thalassemia Major  (BTM) is an autosomal 
recessive, inherited disorder of haemoglobin synthesis, 
caused by reduced or absent synthesis of beta globin 
chains, resulting in life-threatening anaemia and 
requiring regular blood transfusion for survival. It is 
common in the Mediterranean, Indian subcontinent, 
and Middle East regions. Approximately, 5000-9000 
children with β-thalassemia are born annually in 
Pakistan with an estimated carrier rate of 5-7%.1 Both 
the parents of an affected child are carriers, having a 
single copy of mutated beta globin gene. At each 
conception, the child has 25% chance of being affected, 
50% chance of being an asymptomatic carrier, and 25% 
chance of being normal.2 High fertility and birth rate, 
low educational status, trends of consanguineous 
marriages and lack of awareness are some of the 
reasons that have made this disease highly prevalent 
in Pakistan.3 The mainstay to control this preventable 
disease is by population screening, appropriately 
timed genetic counselling, prenatal diagnosis and 
option of terminating affected pregnancies.1 The 
preferred method for prenatal diagnosis is detection of 
beta- chain mutation by polymerase chain reaction 
(PCR) of fetal DNA obtained by chorionic villous 
sampling (CVS). This technique can prevent the birth 
of an affected child in developing countries in which 
Beta-thalassaemia is very much prevalent. This facility 
initially reported in 1994, is now available at many 
centers in the country and offered to all couples at risk 
for a child with BTM. CVS is performed at 10-12 weeks 
of gestation by trans-abdominal route, and after 
seeking appropriate level of training and performance 
of initial procedures under supervision, it is a simple, 
easy to apply, useful, and fairly safe technique. In 
comparison to estimated total cost of the long-term 
treatment of beta -thalassaemia, cost required for CVS 
and laboratory diagnosis of Beta- thalassaemia 
mutation is minimal. In cases where fetus is detected 
to be homozygous for Beta -thalassaemia mutation, 
termination is done soon after the diagnosis, usually 
from 13-16th weeks of gestation which is usually 
uneventful and without any untoward complications.4  
Subjects and Methods 
This was a cross-sectional descriptive study, which 
was based on a pre-designed structured questionnaire. 
It was conducted in the Thalassaemia Center, Children 
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Hospital, Pakistan Institute of Medical Sciences 
(P.I.M.S) Islamabad, Pakistan from January to March 
2017. Parents of 210 registered patients of BTM, who 
had history of at least one pregnancy after the index 
case, were included in the study. Parents having 
children with any other haemoglobinopathy, Beta-
Thalassaemia Intermedia and those having only a 
single child were excluded from the study. A carefully 
designed questionnaire was used to collect data from 
either of the parents available with the child at the 
time of interview, regarding socio-demographic status, 
number of thalassaemic children, family history and 
previous knowledge of thalassaemia,provision of 
genetic counseling at the time of diagnosis of first 
thalassaemic child, parents’ future pregnancy plan and 
approximate treatment related expenses. They were 
also inquired if they had opted for CVS or not; and if 
not, reasons for not opting. All data was entered and 
analyzed using SPSS version 20 and a p-value of <0.05 
was considered statistically significant. 
 
Results 
(54.3%) belonged to lower middle class (Table 1). 
Majority can not bear the expenses more than 10,000 
per month (Table 2). The total number of children in 
the families under study ranged from 2 – 10, with 
majority parents (31.9%) having 3 children. Out of 
those, number of children suffering from BTM  ranged 
from 1-4. Most of the families (63.3%) had 1 
thalassaemic child, followed by 2 in 66 (31.4%) of the 
families. Only 22 (10.5%) parents had previous 
knowledge about the mode of inheritance of 
thalassaemia, regardless of the family history. None of 
the parents had received pre-marital screening and no 
parent reported any complication following CVS. The 
2 major reasons among parents not practicing CVS 
testing in 1 or more pregnancies,  were lack of proper 
knowledge about CVS in 64(47.7%) and careless 
attitude in 56 (41.7%) (Table 3). Majority  (52.8%) had 
no planning, 66(31.4%) were practicing family 
planning methods and 33(15.7%) desired 1 or more 
children in future after undergoing CVS prenatally. 
There was significant association between the trend of 
opting for CVS among the parents and educational 
level of the mother (p=0.008). Similarly, if the parents 
were offered good genetic counseling at the time of 
diagnosis of first thalassaemic child, there was a 
higher trend of practicing CVS in the subsequent 
pregnancies (p <0.05). However, neither the 
educational level of the father nor the financial status 
of the family had any significant association with the 
CVS practice. 
Table I : Socio-demographic profile of families 
 N % 
Residence 
Province-wise 
distribution 
(n=210) 
 
 
Punjab 
Federal Capital 
KPK 
AJK 
FATA 
Sindh 
106 
54 
32 
16 
01 
01 
50.4 
25.7 
15.2 
7.6 
0.4 
0.4 
Educational 
Status 
(n=210) 
Mothers: 
 
 
 
 
 
Fathers: 
Uneducated 
Under-primary 
Primary 
Under-matric 
Matric 
Inter 
Graduate 
Masters 
72 
09 
27 
24 
46 
16 
10 
06 
34.3 
4.3 
12.9 
11.4 
21.9 
7.6 
4.8 
2.9 
Uneducated 
Under-primary 
Primary 
Under-matric 
Matric 
Inter 
Graduate 
Masters 
40 
12 
21 
30 
65 
18 
15 
09 
19.0 
5.7 
10.0 
14.3 
31.0 
8.6 
7.1 
4.3 
Financial 
status 
(with average 
monthly 
income) 
n=210 
Poor (<5000 Rs.) 
Lower Middle (5000-
15,000 Rs.) 
Middle (15,000-50,000 Rs.) 
Upper Middle (>50,000 
Rs.) 
38 
114 
55 
03 
18.1 
54.3 
26.2 
1.4 
 
Table 2: Treatment related expenses  
per month (Pkr) 
 No. of Families No (%) 
<1000 Rs 76 36.1% 
1000-5000 Rs 89 42.3% 
5000-10,000 Rs 27 12.8% 
>10,000 Rs 18 8.5% 
 
Discussion 
 About 3% of the world’s population carries the genes 
for beta thalassaemia; the carrier rate in Pakistan 
ranges between 5-8%. Around 5000 children are 
diagnosed annually with BTM in Pakistan; 
consanguinity being one of the major factors leading to 
its high prevalence in the country.5In a family having a 
patient of BTM (extended family) the prevalence of 
carrier is more than 30%.6 
As in many other developing countries in Asia, β- 
thalassaemia increases the burden for healthcare 
services in Pakistan and with limited available 
national resources, it is very difficult to provide safe  
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Table  3. Knowledge, attitudes and practices 
among parents  regarding prenatal diagnosis by 
CVS. 
 No % 
Genetic 
Counseling 
offered(n=210) 
Yes 
No 
140 
70 
66.6 
33.3 
CVS undergone 
after the index 
case (n=210): 
Never 
In some pregnancies 
In all pregnancies 
97 
37 
76 
46.2 
17.6 
36.2 
Reasons for not 
opting for CVS 
(n=134) 
Lack of proper knowledge 
Careless attitude 
Family Pressure 
Financial reason 
Health Concerns 
Non-availability of one 
parent 
Transportation problem 
Late diagnosis of index 
case 
64 
 
56 
06 
02 
02 
02 
01 
01 
47.7 
 
41.7 
4.4 
1.5 
1.5 
1.5 
0.7 
0.7 
Termination of 
pregnancy 
sought after 
diagnosis of 
Thalassemia 
major on CVS 
(n=32) 
Yes 
No 
27 
05 
84.3 
15.7 
 
blood transfusion and iron chelation therapy to each 
and every patient. 7 Multidisciplinary approach is 
needed to treat this disease but it is difficult due to 
shortage of resources and poor coordination among 
the existing facilities.8 Bone marrow transplantation, 
the only curative option, is extremely expensive and 
unaffordable for most Pakistani patients. Therefore, 
prevention is the most effective and the least 
expensive option available, to deal with β-thalassemia 
in our country. 7 
Different strategies to prevent thalassemia include 
parental awareness, population screening, genetic 
counseling, and prenatal diagnosis. Creating 
awareness and educating parents is a cost-effective 
tool in preventing and improving the quality of life of 
patients with thalassemia. 8,9 The developed countries 
are more focused at preventing the disease by 
detection of thalassemia carriers and marriage 
counseling.10,11 In Cyprus, the incidence of BTM  cases 
dropped by 96% through preventive programs. 12 The 
provision of CVS sampling in the first trimester of 
pregnancy makes it more acceptable. It is preferable to 
do CVS before 120 days (17 weeks) of pregnancy. In 
one study, almost all prenatal diagnoses were carried 
out in the first trimester with >95% of women opting 
for termination of pregnancy in case of BTM fetus. 13 In 
case of homozygous fetus, termination is physically 
and emotionally more feasible and acceptable in the 
earlier stages of pregnancy. The results of one study 
showed that the performance of CVS test was reliable; 
especially considering the validity and predictive 
value in the diagnosis of thalassaemia major. Thus, 
couples with thalassemia trait can safely undergo this 
test to prevent the birth of the children with major 
thalassaemia.14 
In Pakistan, Punjab Thalassaemia Prevention 
Programme (PTPP) has been started by the 
Government of Punjab to provide free Prenatal 
Diagnostic service (Collection of chorionic villous 
sample and mutation analysis) which is catering whole 
of the province through its field officers, especially 
covering the districts of Rawalpindi, Mianwali, 
Jhelum, Gujrat, Chakwal, Khoshab, Sargodha and 
Attock. People from Khyber Pukhtoon khwa , Gilgit 
Baltistan and Azad Jammu and Kashmir are also 
taking advantage through this initiative .15 
In our study, most of the patients, 106 (50.4%) were 
residents of Punjab province, followed by 54 (25.7%) 
from Federal Capital Islamabad and 32 (15.2%) from 
KPK. The Thalassemia Center at PIMS Islamabad has 
more than 1500 patients of thalassaemia registered and 
caters for the transfusion services of many of the 
patients from these parts of the country. Regarding the 
educational level of the parents, majority of the 
mothers, 72(34.3%) were uneducated and majority of 
the fathers, 65(31%) had received formal education up 
to matric level. This is comparable to other studies 
done in the same context in different settings in 
Pakistan. Ali S. et al. 10,16,17   
Positive family history for thalassemia was found in 
26% cases. Despite a high rate of consanguineous 
marriages in our country, the prevalence of positive 
family history is low in present study. Most of the 
families, 114 (54.3%) belonged to lower-middle class 
with an average income of Rs. 5000-15,000/month. The 
maximum number of parents that is 89 (42.3%) spent 
between Rs. 1000-5000/month on the treatment of 
their one or more thalassaemic children. The 
expenditures included money spent on travelling, 
food, stay and medicines. Majority of the patients were 
supported by The Bait-ul-Maal Pakistan as well as by 
Hospital Zakat Funds. In a study conducted in India, 
they found that the average annual cost of treatment 
was $137.9±47.8, the expenditure included amount  
spent for blood transfusion and related expenses, iron 
chelation therapy (if prescribed), folate and calcium 
supplementation therapy, investigations (viz. serum 
ferritin level, Hb estimation), splenectomy (if done in 
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last 1 yr), vaccination for Hepatitis B and others like 
treatment costs for adverse effects of transfusion.18 
A study from Iran showed that proper genetic 
counseling teams consisting of a doctor and a 
professional with a BSc. degree in health studies were 
established in designated accessible urban health posts 
in every city.19A formal genetic counseling session 
should include explanation of the nature and 
prognosis of the disorder and available treatment 
options, estimation and communication of genetic risk 
for parents and providing options for avoiding them 
including technique of prenatal diagnosis and 
associated problems and supporting the individual or 
couple in making the decision that is right for them.20 
In present study a significant association between 
genetic counselling and undergoing CVS testing (p 
<0.05). In the present study, only 76 (36.2%) parents 
had undergone CVS in all subsequent pregnancies, 
while the majority 97 (46.2%) had never opted for CVS 
testing. Another study showed that after the index 
case, 72% families did not undergo prenatal diagnosis 
of thalassemia by CVS.21 Common reasons in our 
study were lack of awareness about prenatal testing 
(47.7%) and careless attitude by the parents (41.7%). 
Despite the fact that majority of the families belonged 
to lower middle class, financial reasons were found in 
only 1.5% of the cases. This might be because CVS is 
done free of cost now at few Government-based 
Centers. In spite of the common notion in our country 
that termination of pregnancy is not religiously 
permitted, our study showed no significant 
relationship between not undergoing CVS and 
religious reasons. In one study comparable to ours, 
CVS was not advised in 48% families and there were 
24% families in which it was advised but they did not 
opt for it. 21  In another study 37.5% knew about 
prenatal diagnosis but did not use it.22 
Termination of pregnancy (TOP) was done in 84% of 
families after the diagnosis of thalassemia on CVS. In 
the rest, reasons for not opting TOP were delay in 
collecting report and reaching hospital in time 
especially in those patients who belong to far flung 
areas where there is no local specialized center for 
prenatal diagnosis. In a study conducted in Saudi 
Arabia, the attitude towards abortion was greatly 
affected by religious values. 23Another study in Egypt 
showed that the change in attitude towards 
termination of pregnancy was related to good 
counseling of the religious aspects towards prenatal 
diagnosis and termination of pregnancy.[24]In 
comparison, a study done to assess attitudes towards 
prenatal diagnosis and termination of pregnancy for 
thalassemia in pregnant Pakistani women in the North 
of England showed influence by various other factors, 
similar to our findings. 25  It can therefore be concluded 
that religion should not be taken as a proxy for their 
attitudes either for or against termination of 
pregnancy. 
 
Conclusion 
1.Beta-Thalassemia Major poses a major burden of 
disease in our country, and prevention is the only way 
to reduce its incidence.  
2. Prenatal Diagnosis by Chorionic Villous Sampling is 
a safe procedure to detect cases, but non- utilization of 
this facility is evident, due to lack of awareness. 
Religious reasons were not found in any of our cases. 
3.Specialized genetic counseling sessions at the time of 
diagnosis of thalassaemia child regarding family 
screening and prenatal diagnosis emphasizing on its 
long term benefits should be carried out. 
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